The Spine Journal 

TL;DR: This review did not identify any studies estimating the total costs of LBP in the United States from a societal perspective, but such studies may be helpful in determining appropriate allocation of health-care resources devoted to this condition.

TL;DR: An estimate of adverse events associated with rhBMP-2 use in spine fusion is suggested ranging from 10 to 50 times the original estimates reported in the industry-sponsored peer-reviewed publications, as well as a clear increased risk of complications and adverse events to patients receiving rhB MP-2 in spinal fusion.

TL;DR: An ideal means of determining the MCID for a given intervention is yet to be determined and it is possible to develop a useful method provided that the assumptions and methodology are initially declared.

TL;DR: The XLIF approach allows for anterior access to the disc space without an approach surgeon or the complications of an anterior intra-abdominal procedure.

TL;DR: A review of prospectively collected patient-reported outcomes data shows the minimum detectable change (MDC) appears as a statistically and clinically appropriate MCID value.